【2h】

Mohs Surgery in Patients Immunobullous Diseases

机译:莫氏手术治疗免疫性球菌病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Mohs surgery is one of the most effective treatment options for skin cancers as it offers one of the highest chances for cure. Mohs surgery is a precise technique that removes a layer at a time. Although this may be advantageous, this treatment method is difficult in patients with immunobullous diseases. Currently the guidelines for Mohs surgery do not discuss the premanagement of immunobullous patients about to undergo Mohs surgery. >Objective: To advocate for increasing prednisone dose in patients with immunobullous disease prior to undergoing Mohs surgery. >Case Report: The authors present a case of an excision of a squamous cell carcinoma from a 94-year-old woman with a history of pemphigus vulgaris using Mohs micrographic surgery. >Conclusion: Current preoperative guidelines for Mohs surgery do not address the issue of altering steroid medications for patients with immunobullous disease prior to the procedure. The authors suggest that patients with a history of immunobullous disease undergoing Mohs micrographic surgery should have an increase in steroid dose prior to surgery.
机译:>背景:莫氏手术是皮肤癌最有效的治疗方法之一,因为它提供了最高的治愈机会之一。莫氏手术是一种精确的技术,可以一次去除一层。尽管这可能是有利的,但是这种治疗方法在患有免疫性大疱性疾病的患者中很困难。目前,Mohs手术指南并未讨论即将接受Mohs手术的免疫巨瘤患者的预管理。 >目的:提倡在进行Mohs手术之前增加免疫性巨牛病患者的泼尼松剂量。 >病例报告:作者介绍了一例使用Mohs显微外科手术切除一名患有寻常性天疱疮史的94岁女性鳞状细胞癌的案例。 >结论:当前的Mohs手术术前指南并未解决在手术前对患有免疫性球虫病的患者更换类固醇药物的问题。作者建议接受Mohs显微外科手术治疗且具有免疫性巨球病病史的患者在手术前应增加类固醇剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号